<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Teerlink, John R.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Relaxin Reduces Dyspnea, Cardiovascular Death, and Rehospitalization in Acute Heart Failure</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2009-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-13</style></pages><abstract><style  face="normal" font="default" size="100%">Relaxin, a naturally occurring vasodilator, improves symptoms and lessens the risk of cardiovascular death and heart failure rehospitalization in patients hospitalized with acute heart failure, according to findings from the Preliminary Study of Relaxin in Acute Heart Failure [Pre-RELAX-AHF; NCT00520806].</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">9</style></volume></record></records></xml>